The plot is even thicker when you start looking at the FDA’s method for awarding
the PR contract. …
This year’s Nobel Prize awards discoveries of two viruses causing severe human
diseases. …
“After questioning about 20 doctors and research institutions, it looks like
problems with transparency are everywhere,” Grassley told the New York
Times. “The current system for tracking financial relationships isn’t
working.” …
Some researchers question whether these non-cyanocobalamin supplements are
stable in their oral form. For this reason, much larger amounts are typically
used with hope that at least some are absorbed intact. One study suggests that
once absorbed, methylcobalamin may be retained in the body better than
cyanocobalamin.30
…
The advantage using hydroxocobalamin is the lack of adverse effects seen with
the nitrites such as methemoglobinemia and hypotension. It works by exchanging
the hydroxy group for cyanide to form the non-toxic cyanocobalamin (vitamin
B12). …
The hydroxocobalamin neutralizes cyanide by fixing it to form cyanocobalamin
(vitamin B12) which is excreted in the urine. It does not have the problem of
reducing the blood’s capacity to carry oxygen as in the case of nitrite
administration. Hydroxocobalamin is red in color and will turn the mucous
membranes, skin, and urine red, which could interfere with clinical laboratory
tests which depend on color. …
The antitode used in Europe is hydroxocobalamin, a precursor to Vitamin B-12.
The drug is given intravenously and neutralizes cyanide to form cyanocobalamin,
Vitamin B-12, which the body expells by urination. …
The major classes of prescription drugs are failures. Most drugs are never
designed to address the underlying biochemical causes of disease — and they may
intentionally be designed to create life-long dependency. …
Olanzapine long-acting injection is an investigational formulation that combines
olanzapine, an atypical antipsychotic, with pamoic acid resulting in a salt that
sustains the delivery of olanzapine for a period of up to four weeks.
Long-acting injectables have been associated with improved treatment for
patients who struggle with adherence to oral medications.(i) …
The lawsuit alleges that “Merck’s costly promotional campaign was intended to
convince purchasers that the drug was not only safe, but that they should demand
it from their healthcare professionals for pain treatment,” according to a
statement from the attorney general. …